NASDAQ:NTRB
Nutriband
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
nutriband.comipo date
Oct 01, 2021
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other prod...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus